comparemela.com

Latest Breaking News On - Ryaltris - Page 1 : comparemela.com

SK Capital Partners: SK Capital Closes Acquisition of Valtris Specialty Chemicals

SK Capital Partners ("SK Capital"), a New York-based private investment firm focused exclusively on the specialty chemicals, materials and pharmaceuticals sectors, today announced that its affiliates

United statesKostenloser wertpapierhandelJack norrisDaniel abramsonLatham watkinsBackbay communicationsCerberus business financeNew york basedValtris specialty chemicalsNorth americaManaging directorBay communications

Glenmark Specialty S A and Lotus International Pte Ltd enter into exclusive licensing agreement for commercializing Ryaltris Nasal Spray in Singapore, Hong Kong and Vietnam

Mumbai (Maharashtra) [India], January 20 (ANI/PRNewswire): Glenmark Pharmaceuticals Ltd

United statesHong kongUnited kingdomRepublic ofCzech republicSouth africaSouth koreaRobert crockartPetar vazharovUdaykumar murthySeqirus ptyYuhan corporationLotus pharmaceutical co ltdCorporate communicationsLotus international pteGlenmark pharmaceuticals limited

Glenmark gets marketing approval for Ryaltris in 13 EU, UK countries

Mumbai: Global pharma company, Glenmark Pharmaceuticals Limited, has recently announced that the company has received marketing approval for its fixed-dose combination nasal spray Ryaltris in 13.

United kingdomCzech republicSouth africaSaudi arabiaSouth koreaRobert crockartAgency complete response letterDrug administrationGlenmark pharmaceuticalsYuhan corporationSeqirus pty ltdMenarini groupHikma pharmaceuticalsBausch healthChina coGlenmark pharmaceuticals limited

Glenmark Pharmaceuticals Ltd: Glenmark receives marketing approval for Ryaltris, an innovative combination nasal spray, in 13 countries across the EU and UK

- Ryaltris is a fixed dose combination nasal spray that combines an antihistamine (Olopatadine) with a steroid (Mometasone Furoate) for treatment of allergic rhinitis - Ryaltris has been

United kingdomCzech republicSouth africaSaudi arabiaSouth koreaRobert crockartUdaykumar murthyMometasone furoateAgency complete response letterDrug administrationGlenmark pharmaceuticalsYuhan corporationSeqirus pty ltdMenarini groupCorporate communicationsGlenmark pharmaceuticals limited

Glenmark bags marketing approval for Ryaltris in 13 countries across EU, UK

Ryaltris will be marketed in the rest of Europe by the Menarini Group as part of its exclusive licensing agreement with Glenmark

Czech republicUnited kingdomRobert crockartMenarini groupGlenmark pharmaceuticalsHikma pharmaceuticalsBausch healthChief commercial officerNasal spray

vimarsana © 2020. All Rights Reserved.